These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 33111631)

  • 1. Identification of lnc RNAs Related to Prognosis of Patients With Colorectal Cancer.
    Sun Y; Peng P; He L; Gao X
    Technol Cancer Res Treat; 2020; 19():1533033820962120. PubMed ID: 33111631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring prognostic potential of long noncoding RNAs in colorectal cancer based on a competing endogenous RNA network.
    Yang ZD; Kang H
    World J Gastroenterol; 2020 Mar; 26(12):1298-1316. PubMed ID: 32256018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non-coding RNA profile study identifies a metabolism-related signature for colorectal cancer.
    Lu Y; Wang W; Liu Z; Ma J; Zhou X; Fu W
    Mol Med; 2021 Aug; 27(1):83. PubMed ID: 34344319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of MFI2-AS1, a Novel Pivotal lncRNA for Prognosis of Stage III/IV Colorectal Cancer.
    Luo R; Song J; Zhang W; Ran L
    Dig Dis Sci; 2020 Dec; 65(12):3538-3550. PubMed ID: 31960204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of a novel six-long non-coding RNA signature predicting survival of colorectal cancer patients.
    Fan Q; Liu B
    J Cell Biochem; 2018 Apr; 119(4):3574-3585. PubMed ID: 29227531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of long noncoding RNAs biomarkers for diagnosis and prognosis in patients with colon adenocarcinoma.
    Huang W; Liu Z; Li Y; Liu L; Mai G
    J Cell Biochem; 2019 Mar; 120(3):4121-4131. PubMed ID: 30269368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant expression of long noncoding RNA SNHG15 correlates with liver metastasis and poor survival in colorectal cancer.
    Huang L; Lin H; Kang L; Huang P; Huang J; Cai J; Xian Z; Zhu P; Huang M; Wang L; Xian CJ; Wang J; Dong J
    J Cell Physiol; 2019 May; 234(5):7032-7039. PubMed ID: 30317592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a novel hypoxia-immune-related LncRNA risk signature for predicting the prognosis and immunotherapy response of colorectal cancer.
    Luan L; Dai Y; Shen T; Yang C; Chen Z; Liu S; Jia J; Li Z; Fang S; Qiu H; Cheng X; Yang Z
    Front Immunol; 2022; 13():951455. PubMed ID: 36189298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and Validation of Six Autophagy-related Long Non-coding RNAs as Prognostic Signature in Colorectal Cancer.
    Cheng L; Han T; Zhang Z; Yi P; Zhang C; Zhang S; Peng W
    Int J Med Sci; 2021; 18(1):88-98. PubMed ID: 33390777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer.
    Fan CN; Ma L; Liu N
    J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive analysis of the long noncoding RNA expression profile and construction of the lncRNA-mRNA co-expression network in colorectal cancer.
    Zhang Q; Ding Z; Wan L; Tong W; Mao J; Li L; Hu J; Yang M; Liu B; Qian X
    Cancer Biol Ther; 2020; 21(2):157-169. PubMed ID: 31619123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive ceRNA network analysis and experimental studies identify an IGF2-AS/miR-150/IGF2 regulatory axis in colorectal cancer.
    Liu B; Liu Y; Zhou M; Yao S; Bian Z; Liu D; Fei B; Yin Y; Huang Z
    Pathol Res Pract; 2020 Oct; 216(10):153104. PubMed ID: 32853944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of the 3-lncRNA Signature as a Prognostic Biomarker for Colorectal Cancer.
    Liu S; Cao Q; An G; Yan B; Lei L
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33302562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of dysregulated lncRNAs profiling and metastasis-associated lncRNAs in colorectal cancer by genome-wide analysis.
    Chen Y; Yu X; Xu Y; Shen H
    Cancer Med; 2017 Oct; 6(10):2321-2330. PubMed ID: 28857495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long noncoding RNAs predict the survival of patients with colorectal cancer as revealed by constructing an endogenous RNA network using bioinformation analysis.
    Zhang H; Wang Z; Wu J; Ma R; Feng J
    Cancer Med; 2019 Mar; 8(3):863-873. PubMed ID: 30714675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and development of long non-coding RNA-associated regulatory network in colorectal cancer.
    Pan H; Pan J; Song S; Ji L; Lv H; Yang Z
    J Cell Mol Med; 2019 Aug; 23(8):5200-5210. PubMed ID: 31144439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-wide analysis of long noncoding RNA (lncRNA) expression in colorectal cancer tissues from patients with liver metastasis.
    Chen D; Sun Q; Cheng X; Zhang L; Song W; Zhou D; Lin J; Wang W
    Cancer Med; 2016 Jul; 5(7):1629-39. PubMed ID: 27165481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulated long noncoding RNAs LINC02163 and FEZF1-AS1 exert oncogenic roles in colorectal cancer.
    Tian Y; Zhou J; Zou Y; Luo B; Liu Q; Cao X
    Anticancer Drugs; 2021 Jan; 32(1):66-73. PubMed ID: 32932277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long noncoding RNA HNF1A-AS1 indicates a poor prognosis of colorectal cancer and promotes carcinogenesis via activation of the Wnt/β-catenin signaling pathway.
    Zhang X; Xiong Y; Tang F; Bian Y; Chen Y; Zhang F
    Biomed Pharmacother; 2017 Dec; 96():877-883. PubMed ID: 29145164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low expression of novel lncRNA RP11-462C24.1 suggests a biomarker of poor prognosis in colorectal cancer.
    Shi D; Zheng H; Zhuo C; Peng J; Li D; Xu Y; Li X; Cai G; Cai S
    Med Oncol; 2014 Jul; 31(7):31. PubMed ID: 24908062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.